Analyst Ratings for Astrana Health, Inc (ASTH)
ASTH Rating Summary
ASTH Price Target Summary
- Highest: $50.00 (TD Cowen)
- Lowest: $37.00 (Jefferies)
- Average: $45.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$45.00 (+0.1%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$45.00 (+0.1%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/26/2026 | Barclays | Andrew Mok | Upgrade | Overweight (Equalweight) |
50.00 (37.00) |
37.85 (44.94) |
18.73% | Details |
| 12/12/2025 | Needham » Updated 5/8/2026 |
Matthew Shea | New Coverage | Buy (N/A) |
41.00 (30.00) |
22.46 (44.94) |
100.09% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
